High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains

J Neural Transm (Vienna). 1997;104(8-9):921-9. doi: 10.1007/BF01285560.

Abstract

Specific binding of [3H]imipramine and [3H]paroxetine was simultaneously examined in human brains (frontal cortex, temporal cortex, cingulate cortex, hypothalamus, hippocampus and amygdala) from 11 controls and 11 depressed suicide victims. A single saturable high affinity site was obtained for both radioligands. Age was not related to significant changes in [3H]imipramine and [3H]paroxetine binding parameters, which indicates the stability of the brain serotonergic system with increasing age. A major finding of the present study concerns the existence of a significant decrease in the maximum number (Bmax) of [3H]imipramine binding sites in hippocampus from depressed suicides as compared with the control group, without changes in the binding affinity (Kd). In contrast, when [3H]paroxetine was used as radioligand, no changes in either Bmax or Kd were detected in any of the brain regions studied. These findings suggest that [3H]imipramine may be a better marker than [3H]paroxetine when alterations in the presynaptic serotonergic uptake site are to be detected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Binding Sites
  • Brain / metabolism*
  • Depression / metabolism*
  • Female
  • Humans
  • Imipramine / metabolism*
  • Male
  • Middle Aged
  • Paroxetine / metabolism*
  • Selective Serotonin Reuptake Inhibitors / metabolism*
  • Serotonin / metabolism
  • Suicide*

Substances

  • Serotonin Uptake Inhibitors
  • Serotonin
  • Paroxetine
  • Imipramine